Showing results (891-900 of 1,025) with videos related to
Sort By:
Pageof 103
Nucleic Acids Research|September 2, 2006
Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown miceAngus T De Souza, Xudong Dai, Andrew G Spencer, et al.Pancreas|September 14, 2017
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant ChemotherapyReza Nejati, Jennifer B Goldstein, Daniel M Halperin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancerChristopher H Crane, Lee M Ellis, James L Abbruzzese, et al.International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistanceScott Kopetz, Paulo M Hoff, Jeffrey S Morris, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 31, 2012
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resectionRyan M Thomas, Mark J Truty, Graciela M Nogueras-Gonzalez, et al.Annals of Surgical Oncology|January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyChing-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.Journal of Gastrointestinal Oncology|January 13, 2017
Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution patternHumaid O Al-Shamsi, Jeremy Jones, Yazan Fahmawi, et al.Cancers|October 16, 2024
The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyMehran Taherian, Matthew H G Katz, Laura R Prakash, et al.Pageof 103